 |
 |
 |
Home |
| Dr. Daniel O' Mahony Partner, Seroba Kernel Partner, Kernel Capital |
 |
| Dr. Daniel O’ Mahony has
26 years international experience at a senior level of management in industry
and scientific research, ten years of which were at Elan Corporation where
he held the positions of VP Technology & Asset Divestment and VP Experimental
Biology followed by R&D Director at Taro Pharmaceuticals. He has held
academic posts at the Biochemistry Department, University College Cork;
the Genetics Department, Trinity College, Dublin; The Weis Research Centre,
PA, USA; the Department of Medicine & Experimental Therapeutics, University
College Dublin and the Mater Hospital Centre for Cardiovascular Science. He
established the very successful Technology Transfer Office at the National
University Ireland, Galway in 2005. His skills encompass major aspects of biopharmaceutical and biotechnology industries, technology licensing from university sector and campus company formation. He is a named inventor on 25 patents, author of over 40 publications and presenter and speaker at numerous international conferences. He sits on the board of a number of private companies. He holds a Ph.D in biochemistry and molecular genetics from University College Cork and a business degree in technology management from the Smurfit business school, University College Dublin. He has been a member of Kernel Capital Advisory board since 2002 and since then he has lead over 25 comprehensive due diligence reviews on behalf of the firm. He commenced a full time position with Kernel as a Partner in January 2008. | |
Kernel Management Partners Limited, trading as Kernel Capital, is regulated by the Central Bank of Ireland. |